Sort
39,280 grants matching “leukemia”
Novel Spliceosomal Defects in Myelodysplastic Syndromes
$622,914Jaroslaw P Maciejewski · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · HL
Administrative Core
$622,731Monica M Bertagnolli · Brigham And Women'S Hospital · U10 · FY2019 · CA
Mitochondrial iron export therapy for doxorubicin-induced cardiotoxicity
$622,565Jonghan Kim · University Of Massachusetts Lowell · R01 · FY2024 · HL
Constrained Fetal Hematopoiesis and Clonal Restriction in Fanconi Anemia
$622,503Peter Kurre · Children'S Hosp Of Philadelphia · R01 · FY2021 · HL
O-Glycosylation of Epidermal Growth Factor-like Motifs
$622,378Robert S. Haltiwanger · State University New York Stony Brook · R01 · FY2016 · GM
Predicting and Monitoring for Cardiac Toxicity in Pediatric AML
$622,359Richard Aplenc · Children'S Hosp Of Philadelphia · R01 · FY2024 · HL
Modeling and Predicting Therapeutic Resistance of Cancer
$622,359Dean W Felsher · Stanford University · U01 · FY2014 · CA
Preclinical Testing of PI3K Inhibitors for Vestibular Schwannomas
$622,304Cristina Maria Fernandez-Valle · University Of Central Florida · R01 · FY2019 · DC
Genetic and molecular basis for SRSF2 mutations in myelodysplasia
$622,278Robert K Bradley · Fred Hutchinson Cancer Research Center · R01 · FY2019 · HL
Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care
$622,247Cynthia Ann Toth · Duke University · R01 · FY2021 · EY
Integration of germline and tumor genomes in CLL
$622,223Susan L Slager · Mayo Clinic Rochester · R01 · FY2023 · CA
Activation of Proto-Oncogenes by Chromosomal Translocation
$622,092Peter Aplan · Division Of Clinical Sciences - Nci · ZIA · FY2020 · CA
Pre-clinical Studies of Therapy for Myelodysplastic Syndrome
$622,092Peter Aplan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Collaborative Pathways that Lead to Leukemia
$622,092Peter Aplan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Metabolic Reprogramming in Brain Tumors
$622,068Sabrina Miriam Ronen · University Of California, San Francisco · R01 · FY2016 · CA
iPSC-based blood regenerative therapies for AIDS
$622,020Igor I Slukvin · University Of Wisconsin-Madison · R01 · FY2013 · HL
Towards an inclusive genomic risk classification for acute myeloid leukemia (AML)
$622,018Ann-Kathrin Eisfeld · Ohio State University · R01 · FY2024 · CA
Tailoring CAR T cell therapy for Hodgkin Lymphoma
$622,000Barbara Savoldo · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
In vivo studies of megakaryocyte microRNAs regulating platelet number and integrin activation
$621,727Paul F. Bray · University Of Utah · R01 · FY2019 · HL
Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence
$621,705Elizabeth Bouchard · Roswell Park Cancer Institute Corp · R01 · FY2024 · CA
COPII dependent regulation of T cell alloimmunity
$621,640Pavan Reddy · Baylor College Of Medicine · R01 · FY2023 · HL
Novel enhancement of antibody therapy through NOD2 activation
$621,637Susheela Tridandapani · Ohio State University · R01 · FY2024 · CA
Discovery of First-in-class WDR5 PROTACs as a Novel Therapeutic Strategy for MLL-rearranged Leukemias
$621,637Jian Jin · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
REGULATION OF HEMATOPOIETIC PROGENITORS BY DE NOVO DNA METHYLATION
$621,634Margaret Goodell · Baylor College Of Medicine · R01 · FY2024 · DK
Lentiviral Gene Therapy and Genome Editing for Wiskott-Aldrich Syndrome
$621,596David J Rawlings · St. Jude Children'S Research Hospital · P01 · FY2019 · HL